This episode we revisit another psychedilic MDMA.  Its crazy how there are people that abhorrently deny the benefit of these "recreational" drugs. I am giving some brief data on how MDMA can prove useful.'

MAPS clinical trial- http://bit.ly/2FNZP78

 Current Perspective on MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder -http://bit.ly/2I4Q6eb

Move over anti-depressents there's a new MOA in town. This episode details a new intranasal ketamine produce by Janssen pharmaceuticals. 

This is a brief look at the data we have so far. Enjoy!

SPRAVATO- http://bit.ly/2URxZfv

Pharmacology of Ketamine study-  http://bit.ly/2HyzETT

This episode delves into a drug that most of us need on a daily basis. CAFFEINE. This wonder molecule affects so many of our body's processes.

If your curious how it works and what makes it affect you so profoundly, give this episode a listen.

Enjoy!

Genetics of caffeine consumption and responses to caffeine- http://bit.ly/2XJDSwY

This episode revisits why statins and if they are as beneficial as currently believed. There are many nuances about statins and confusion. Hopefully this episode clears things up!

Saturated fat is not the major issue -http://bit.ly/2GxkgH9

 Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above - http://bit.ly/2T9e5P8

Interpretation of the evidence for the efficacy and safety of statin therapy - http://bit.ly/2T9Sbvv

Long-term moderately elevated LDL-cholesterol and blood pressure and risk of coronary heart disease - http://bit.ly/2twk7Le

Debate on LDL Role in Heart Disease Reignited Out of the Blue -https://wb.md/2tsnUJw

European Atherosclerotic Society Statement - https://wb.md/2tufWzF

AHA safety statement- http://bit.ly/2GMIe0l

Benefits vs. Harm of statins- http://bit.ly/2NdzPE7

This episode is going to go over what I found related the most to in the state of the union address to healthcare.  There were many outlandish claims but this address could have been way worse than it turned out.

https://wb.md/2GtrTgR

This episode is a brief synopsis on trends in the Flu season so far and a new FDA generic approval of a long standing respiratory inhaler.

Influenza upswing- https://wb.md/2UJFnJm

Advair generic- https://wb.md/2TyoD7r

FDA statement on ARBs recalls- http://bit.ly/2DVNxZA

Ibuprofen Recall by Tris Pharm Inc.- http://bit.ly/2RKKzLa

  The various lots recalled include:

Lot 4718 — sold in a .5 oz. bottle with an expiration date of Dec. 2019 — and lot 00717006A — sold in a 1 oz. bottle with an expiration date of Feb. 2019 — were manufactured under the "CVS Health" label, according to the release. Lot 00717005A — sold in a 1 oz. bottle with an expiration date of Feb. 2019 — was manufactured under the "Equate" label for Walmart.

This episode is a brief update on the opioid epidemic.

A Perspective Regarding the Current State of the Opioid Epidemic. | Psychiatry | JAMA Network Open | JAMA Network- http://bit.ly/2WEZaLw

FDA announcemet- http://bit.ly/2DQh8TW

This episode is the introduction into my new format of shorter and more digestible episodes. 

N.Y.C healthcare- https://wb.md/2UzRA

Wyoming patient infected- https://wb.md/2GhTaTw